{"id":"https://openalex.org/W7225160038","doi":"https://doi.org/10.1093/rap/rkag113.026","title":"OA26 Anti-NXP2-Positive Juvenile Dermatomyositis in an Adolescent Following a Five-Year History of Childhood Cutaneous Manifestations, Presenting with Severe Myositis, Bulbar Weakness and Respiratory Failure Complicated by Macrophage Activation Syndrome","display_name":"OA26 Anti-NXP2-Positive Juvenile Dermatomyositis in an Adolescent Following a Five-Year History of Childhood Cutaneous Manifestations, Presenting with Severe Myositis, Bulbar Weakness and Respiratory Failure Complicated by Macrophage Activation Syndrome","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225160038","doi":"https://doi.org/10.1093/rap/rkag113.026"},"language":"en","primary_location":{"id":"doi:10.1093/rap/rkag113.026","doi":"https://doi.org/10.1093/rap/rkag113.026","is_oa":true,"landing_page_url":"https://doi.org/10.1093/rap/rkag113.026","pdf_url":"https://academic.oup.com/rheumap/article-pdf/10/Supplement_1/rkag113.026/72372058/rkag113.026.pdf","source":{"id":"https://openalex.org/S2735938563","display_name":"Rheumatology Advances in Practice","issn_l":"2514-1775","issn":["2514-1775"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology Advances in Practice","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/rheumap/article-pdf/10/Supplement_1/rkag113.026/72372058/rkag113.026.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5134753438","display_name":"Md Shahriar Kabir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093322","display_name":"NHS Grampian","ror":"https://ror.org/00ma0mg56","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210093322"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Md Shahriar Kabir","raw_affiliation_strings":["NHS Grampian Rheumatology Department , Aberdeen,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NHS Grampian Rheumatology Department , Aberdeen,","institution_ids":["https://openalex.org/I4210093322"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012898670","display_name":"Maira Karabayas","orcid":"https://orcid.org/0000-0002-4206-477X","observed_orcids":["https://orcid.org/0000-0002-4206-477X"]},"institutions":[{"id":"https://openalex.org/I4210093322","display_name":"NHS Grampian","ror":"https://ror.org/00ma0mg56","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210093322"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Maira Karabayas","raw_affiliation_strings":["NHS Grampian Rheumatology Department , Aberdeen,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NHS Grampian Rheumatology Department , Aberdeen,","institution_ids":["https://openalex.org/I4210093322"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013928073","display_name":"Paula Dospinescu","orcid":"https://orcid.org/0000-0002-6549-6049","observed_orcids":["https://orcid.org/0000-0002-6549-6049"]},"institutions":[{"id":"https://openalex.org/I4210093322","display_name":"NHS Grampian","ror":"https://ror.org/00ma0mg56","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210093322"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paula Dospinescu","raw_affiliation_strings":["NHS Grampian Rheumatology Department , Aberdeen,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NHS Grampian Rheumatology Department , Aberdeen,","institution_ids":["https://openalex.org/I4210093322"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210093322"],"apc_list":{"value":2255,"currency":"GBP","value_usd":2974},"apc_paid":{"value":2255,"currency":"GBP","value_usd":2974},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/juvenile-dermatomyositis","display_name":"juvenile dermatomyositis","score":0.9929999709129333},{"id":"https://openalex.org/keywords/anti-nxp2-antibodies","display_name":"anti-NXP2 antibodies","score":0.8870000243186951},{"id":"https://openalex.org/keywords/macrophage-activation-syndrome","display_name":"macrophage activation syndrome","score":0.9520000219345093},{"id":"https://openalex.org/keywords/bulbar-weakness","display_name":"bulbar weakness","score":0.8309999704360962},{"id":"https://openalex.org/keywords/respiratory-failure","display_name":"respiratory failure","score":0.9869999885559082},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.6940000057220459},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.996999979019165},{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.8849999904632568},{"id":"https://openalex.org/keywords/critical-care-management","display_name":"intensive care management","score":0.5600000023841858},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.6200000047683716},{"id":"https://openalex.org/keywords/hyperferritinemia","display_name":"hyperferritinemia","score":0.6990000009536743},{"id":"https://openalex.org/keywords/muscle-necrosis","display_name":"muscle necrosis","score":0.3009999990463257}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.960099995136261},{"id":"https://openalex.org/C2778552304","wikidata":"https://www.wikidata.org/wiki/Q6318950","display_name":"Juvenile dermatomyositis","level":3,"score":0.8826000094413757},{"id":"https://openalex.org/C2779613421","wikidata":"https://www.wikidata.org/wiki/Q6725504","display_name":"Macrophage activation syndrome","level":3,"score":0.6879000067710876},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.6283000111579895},{"id":"https://openalex.org/C2909745897","wikidata":"https://www.wikidata.org/wiki/Q270421","display_name":"Proximal muscle weakness","level":4,"score":0.6233000159263611},{"id":"https://openalex.org/C2778751314","wikidata":"https://www.wikidata.org/wiki/Q681160","display_name":"Dermatomyositis","level":2,"score":0.5999000072479248},{"id":"https://openalex.org/C2779999465","wikidata":"https://www.wikidata.org/wiki/Q2094702","display_name":"Muscle biopsy","level":3,"score":0.5795999765396118},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.5223000049591064},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5184000134468079},{"id":"https://openalex.org/C2780181341","wikidata":"https://www.wikidata.org/wiki/Q4117658","display_name":"Inflammatory myopathy","level":3,"score":0.47540000081062317},{"id":"https://openalex.org/C2781232998","wikidata":"https://www.wikidata.org/wiki/Q1433212","display_name":"Myositis","level":2,"score":0.4422000050544739},{"id":"https://openalex.org/C2780439664","wikidata":"https://www.wikidata.org/wiki/Q7535376","display_name":"Skin biopsy","level":3,"score":0.43380001187324524},{"id":"https://openalex.org/C2778616394","wikidata":"https://www.wikidata.org/wiki/Q474959","display_name":"myalgia","level":2,"score":0.421999990940094},{"id":"https://openalex.org/C2776418732","wikidata":"https://www.wikidata.org/wiki/Q270421","display_name":"Muscle weakness","level":2,"score":0.4212000072002411},{"id":"https://openalex.org/C2779121184","wikidata":"https://www.wikidata.org/wiki/Q1166142","display_name":"Erythema","level":2,"score":0.39340001344680786},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.365200012922287},{"id":"https://openalex.org/C2775934546","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Biopsy","level":2,"score":0.3467000126838684},{"id":"https://openalex.org/C2779123688","wikidata":"https://www.wikidata.org/wiki/Q421094","display_name":"Hydroxychloroquine","level":5,"score":0.3447999954223633},{"id":"https://openalex.org/C2775941666","wikidata":"https://www.wikidata.org/wiki/Q7113759","display_name":"Overlap syndrome","level":3,"score":0.31839999556541443},{"id":"https://openalex.org/C527108885","wikidata":"https://www.wikidata.org/wiki/Q835153","display_name":"Physical examination","level":2,"score":0.31029999256134033},{"id":"https://openalex.org/C2776888751","wikidata":"https://www.wikidata.org/wiki/Q767485","display_name":"Respiratory failure","level":2,"score":0.3089999854564667},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.30880001187324524},{"id":"https://openalex.org/C2777300911","wikidata":"https://www.wikidata.org/wiki/Q692536","display_name":"Myopathy","level":2,"score":0.30149999260902405},{"id":"https://openalex.org/C2780574019","wikidata":"https://www.wikidata.org/wiki/Q861224","display_name":"Juvenile rheumatoid arthritis","level":3,"score":0.2915000021457672},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28870001435279846},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.28360000252723694},{"id":"https://openalex.org/C2775998817","wikidata":"https://www.wikidata.org/wiki/Q1509367","display_name":"Rapidly progressive glomerulonephritis","level":4,"score":0.2797999978065491},{"id":"https://openalex.org/C2780527005","wikidata":"https://www.wikidata.org/wiki/Q2060353","display_name":"Bulbar palsy","level":2,"score":0.2791999876499176},{"id":"https://openalex.org/C2776670291","wikidata":"https://www.wikidata.org/wiki/Q1779300","display_name":"Connective tissue disease","level":4,"score":0.27619999647140503},{"id":"https://openalex.org/C2775917601","wikidata":"https://www.wikidata.org/wiki/Q1424050","display_name":"Sclerodactyly","level":4,"score":0.26840001344680786},{"id":"https://openalex.org/C2781228260","wikidata":"https://www.wikidata.org/wiki/Q415411","display_name":"Anakinra","level":3,"score":0.26589998602867126},{"id":"https://openalex.org/C2780247198","wikidata":"https://www.wikidata.org/wiki/Q633403","display_name":"Weakness","level":2,"score":0.2639999985694885},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.2540000081062317}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/rap/rkag113.026","doi":"https://doi.org/10.1093/rap/rkag113.026","is_oa":true,"landing_page_url":"https://doi.org/10.1093/rap/rkag113.026","pdf_url":"https://academic.oup.com/rheumap/article-pdf/10/Supplement_1/rkag113.026/72372058/rkag113.026.pdf","source":{"id":"https://openalex.org/S2735938563","display_name":"Rheumatology Advances in Practice","issn_l":"2514-1775","issn":["2514-1775"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology Advances in Practice","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13728636","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13728636/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13728636/pdf/rkag113.026.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatol Adv Pract","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/rap/rkag113.026","doi":"https://doi.org/10.1093/rap/rkag113.026","is_oa":true,"landing_page_url":"https://doi.org/10.1093/rap/rkag113.026","pdf_url":"https://academic.oup.com/rheumap/article-pdf/10/Supplement_1/rkag113.026/72372058/rkag113.026.pdf","source":{"id":"https://openalex.org/S2735938563","display_name":"Rheumatology Advances in Practice","issn_l":"2514-1775","issn":["2514-1775"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology Advances in Practice","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225160038.pdf","grobid_xml":"https://content.openalex.org/works/W7225160038.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4400926527","https://openalex.org/W4411793322","https://openalex.org/W4415893988","https://openalex.org/W7124275564","https://openalex.org/W4411790708","https://openalex.org/W3215055363","https://openalex.org/W2197753335","https://openalex.org/W2507955064","https://openalex.org/W4398769062","https://openalex.org/W7099624983"],"abstract_inverted_index":{"Abstract":[0],"Introduction":[1],"Juvenile":[2],"dermatomyositis":[3,192,392,424,465,597,609,638,669],"(JDM)":[4],"is":[5,39,727],"a":[6,34,55,58,107,111,135,409,415,550],"rare":[7],"autoimmune":[8],"inflammatory":[9,432,565],"myopathy":[10,433],"of":[11,50,61,94,106,114,144,153,159,240,334,379,383,390,470,497,511,516,575,580,620,660,693,698],"childhood":[12],"characterised":[13],"by":[14,28,73,290,402,426,614],"proximal":[15,165,270],"muscle":[16,26,44,166,223,225,271,386,400,612,678],"weakness":[17],"and":[18,46,80,97,127,169,185,200,230,247,253,268,281,299,322,342,352,365,370,385,454,466,474,506,513,530,540,583,623,657,680,688,695,719,724],"characteristic":[19],"cutaneous":[20,145,397,412,607],"manifestations.":[21],"Cutaneous":[22],"features":[23],"may":[24,610,663,670],"precede":[25,399,611],"involvement":[27,184,401,473,613,679],"months":[29],"or":[30,134],"even":[31,567,591],"years,":[32,616],"posing":[33],"diagnostic":[35,215,416,487,650],"challenge.":[36],"Anti-NXP2-positive":[37,667],"JDM":[38,71],"associated":[40],"with":[41,57,86,110,120,203,261,317,327,336,362,381,594,629,639,676],"more":[42],"severe":[43,77,304,421,449,677],"disease":[45,438,674],"an":[47,87,115,244,442,491,541,672],"increased":[48],"risk":[49],"systemic":[51],"complications.":[52],"We":[53,102],"present":[54],"teenager":[56],"five-year":[59,112],"history":[60,113],"intermittent":[62,116],"photosensitive":[63,117,555,631],"facial":[64,118],"rash":[65,119],"who":[66],"subsequently":[67,259],"developed":[68,162,313],"rapidly":[69,163,179,440,635],"progressive":[70,164,180,262,318,636],"complicated":[72,289,425],"macrophage":[74,328,427,684],"activation":[75,329,428,685],"syndrome,":[76],"bulbar":[78,183,263,305,450,641],"dysfunction":[79,264],"respiratory":[81,275,452,689],"failure":[82,276,453],"requiring":[83,265,277,598],"intensive":[84,278,309,520,528,599,715],"care,":[85,716],"excellent":[88,542,589,731],"clinical":[89,246,351,480,625],"recovery":[90,539,733],"following":[91,201],"timely":[92,696],"escalation":[93,333,515,579,697],"immunosuppressive":[95,476,581,661,699],"therapy":[96,369,477,582,662,700,723],"multidisciplinary":[98,346,533,585,708],"management":[99,524],"Case":[100],"description":[101],"report":[103],"the":[104,142,151,178,204,238,437,458,468,531,618],"case":[105,406,547],"17-year-old":[108],"boy":[109],"seasonal":[121],"exacerbations.":[122],"Dermatological":[123],"assessment":[124],"demonstrated":[125,220],"periorbital":[126],"periungual":[128],"erythema":[129],"without":[130],"classical":[131],"Gottron":[132],"papules":[133],"shawl":[136],"sign.":[137],"Skin":[138],"biopsy":[139,226],"initially":[140],"raised":[141],"possibility":[143],"lupus":[146],"but":[147,493],"remained":[148],"non-specific,":[149],"highlighting":[150,617],"importance":[152,469,619],"clinicopathological":[154,621],"correlation.":[155],"At":[156],"17":[157],"years":[158],"age,":[160],"he":[161,258,312,358],"weakness,":[167,181,272],"myalgia":[168],"dysphagia":[170],"over":[171],"eight":[172],"weeks,":[173],"necessitating":[174],"hospital":[175],"admission.":[176],"Given":[177],"evolving":[182,503,564,640],"creatine":[186],"kinase":[187],"(CK)":[188],">31,000":[189],"U/L,":[190],"juvenile":[191,241,391,423,464,498,596,608,637,668],"was":[193,197,212,287],"suspected.":[194],"Intravenous":[195],"methylprednisolone":[196],"commenced":[198],"promptly,":[199],"discussion":[202],"regional":[205,711],"paediatric":[206,526,654,712],"rheumatology":[207,655,713],"team,":[208],"intravenous":[209,338],"immunoglobulin":[210],"(IVIG)":[211],"initiated":[213],"while":[214,648],"investigations":[216,570],"were":[217,255],"ongoing.":[218],"MRI":[219],"diffuse":[221],"symmetrical":[222],"oedema,":[224],"showed":[227],"necrotising":[228],"myopathy,":[229,566],"myositis":[231],"immunoblot":[232],"confirmed":[233],"anti-NXP2":[234],"antibody":[235],"positivity,":[236],"establishing":[237],"diagnosis":[239],"dermatomyositis.":[242,499],"Following":[243,355],"initial":[245,443,569],"biochemical":[248,353],"response,":[249],"weekly":[250],"subcutaneous":[251],"methotrexate":[252],"rituximab":[254],"introduced.":[256],"However,":[257],"deteriorated":[260],"nasogastric":[266],"feeding":[267],"worsening":[269],"progressing":[273,419],"to":[274,303,375,420,445,703,729],"care":[279,310,521,529,586,600],"admission":[280,286],"invasive":[282],"mechanical":[283],"ventilation.":[284],"His":[285],"further":[288,337],"right":[291],"lower":[292],"lobe":[293],"pneumonia,":[294],"Klebsiella":[295],"urinary":[296],"tract":[297],"infection":[298],"failed":[300],"extubation":[301],"secondary":[302],"weakness.":[306],"During":[307],"his":[308,376],"admission,":[311],"persistent":[314,553,630],"sinus":[315],"tachycardia":[316],"thrombocytopenia,":[319,504],"hyperferritinaemia,":[320],"hypertriglyceridaemia":[321,507],"elevated":[323],"lactate":[324],"dehydrogenase,":[325],"consistent":[326],"syndrome":[330,429,686],"(MAS).":[331,430],"Timely":[332],"immunosuppression":[335],"methylprednisolone,":[339],"additional":[340],"IVIG":[341],"ciclosporin,":[343],"alongside":[344],"coordinated":[345,523,584],"management,":[347,709],"resulted":[348,535],"in":[349,448,462,536,557,592,627],"sustained":[350,537],"recovery.":[354],"successful":[356],"extubation,":[357],"underwent":[359],"inpatient":[360],"rehabilitation":[361],"physiotherapy,":[363,717],"speech":[364,718],"language":[366,720],"therapy,":[367,721],"occupational":[368,722],"dietetic":[371,725],"input,":[372],"ultimately":[373],"returning":[374],"pre-morbid":[377],"level":[378],"function":[380],"restoration":[382],"swallowing":[384],"strength.":[387],"Discussion":[388],"Recognition":[389],"can":[393,587],"be":[394,646,664],"challenging":[395],"when":[396,568],"manifestations":[398],"several":[403,615],"years.":[404],"This":[405,456],"illustrates":[407],"how":[408],"prolonged":[410,519],"atypical":[411,554],"prodrome":[413],"posed":[414],"challenge":[417],"before":[418],"anti-NXP2-positive":[422,463],"Once":[431],"became":[434],"clinically":[435],"apparent,":[436],"progressed":[439],"despite":[441,734],"response":[444],"treatment,":[446],"culminating":[447],"dysfunction,":[451],"MAS.":[455],"reflects":[457],"aggressive":[459,576,673],"phenotype":[460],"recognised":[461],"reinforces":[467],"early":[471,509],"specialist":[472,653],"initiating":[475],"based":[478],"on":[479],"suspicion,":[481],"rather":[482],"than":[483],"waiting":[484],"for":[485,563],"complete":[486],"confirmation.":[488,651],"MAS":[489,512,694],"remains":[490],"uncommon":[492],"potentially":[494],"fatal":[495],"complication":[496],"In":[500,634],"our":[501],"patient,":[502],"hyperferritinaemia":[505],"prompted":[508],"recognition":[510,574,692],"urgent":[514],"immunosuppression.":[517],"Despite":[518],"support,":[522,726],"between":[525],"rheumatology,":[527],"wider":[532],"team":[534],"neurological":[538],"functional":[543,732],"outcome.":[544],"Ultimately,":[545],"this":[546],"serves":[548],"as":[549],"reminder":[551],"that":[552],"rashes":[556],"children":[558,628],"should":[559,644],"prompt":[560,578,658],"continued":[561,624],"surveillance":[562,626],"are":[571,701],"inconclusive.":[572],"Early":[573,652,691],"disease,":[577],"achieve":[588],"outcomes,":[590],"patients":[593],"life-threatening":[595,681],"support":[601],"Key":[602],"learning":[603],"points":[604],"1.":[605],"Atypical":[606],"correlation":[622],"rashes.":[632],"2.":[633],"involvement,":[642],"treatment":[643],"not":[645],"delayed":[647],"awaiting":[649],"input":[656],"initiation":[659],"crucial.":[665],"3.":[666],"follow":[671],"course":[675],"complications,":[682],"including":[683,710],"(MAS)":[687],"failure.":[690],"essential":[702],"improving":[704],"outcomes.":[705],"4.":[706],"Coordinated":[707],"expertise,":[714],"fundamental":[728],"achieving":[730],"critical":[735],"illness.":[736]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-11-04T00:00:00"}